Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) |
Synonyms 68Ga-DOTA-NI-FAPI04 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Carcinoma | Phase 1 | CN | 01 Apr 2024 | |
Fibrosis | Phase 1 | CN | 01 Apr 2021 | |
Fibrosis, Liver | Phase 1 | CN | 01 Sep 2020 | |
Breast Cancer | Preclinical | DE | 06 Apr 2018 |
Not Applicable | - | - | Deep Neural Network | kkdfquijjk(xxhroqbgnj) = tbwuqrpqwq sixihenbkd (qiedjshgfz ) | - | 09 Jun 2024 | |
Deep Neural Network (Conventional PET) | kkdfquijjk(xxhroqbgnj) = kgatiefqnu sixihenbkd (qiedjshgfz ) | ||||||
Not Applicable | - | FDG68 FAPI 04 (FDG PET CT) | xvjvzwcagj(upsrvqzjsr) = lnxulfetxj rartfyxvsx (uupfkisbrl ) View more | Positive | 28 Aug 2023 | ||
Not Applicable | - | 18F-FDGTA-F2 (18F-FDG PET/CT) | kteqzdxjft(qslkouwotl) = lbmfbulhju yvrwiybrkb (xrkmooaklg ) View more | - | 28 Aug 2023 | ||
Not Applicable | Cardiovascular Diseases Fibroblast Activation Protein(FAP) | - | (Case 1: 66 years old male with colangiocarcinoma) | sgxaykobpq(dkmjzrfqrw) = ckjabmawbi jwliimbdlc (otpitsezvv ) | - | 22 Sep 2022 | |
(Case 2: 69 years old male with smoking and peripheral artery disease history) | sgxaykobpq(dkmjzrfqrw) = ghxigzrtjv jwliimbdlc (otpitsezvv ) | ||||||
Not Applicable | - | 68Ga-FAPI-04 PET/CT | mbardebvkn(rljahgcjxb) = zwlpberyoo uvmlviuray (mdfrohavyl ) | - | 08 Aug 2022 | ||
(18F-FDG PET/CT) | mbardebvkn(rljahgcjxb) = dudsgjindq uvmlviuray (mdfrohavyl ) | ||||||
Not Applicable | Interstitial lung disease due to systemic disease Fibroblast Activation Protein (FAP) | 21 | (SSc-ILD patients) | egxlsofkim(syniurgqds) = whqftebfia rccniisujx (qzrzwhfipz ) View more | - | 02 Jun 2021 |